Financhill
Back

Camurus AB 10K Form

Buy
54

CAMRF
Camurus AB

Last Price:
$64.23
Seasonality Move:
17.36%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CAMRF News And Ratings

See the #1 stock for the next 7 days that we like better than CAMRF

CAMRF Financial Statistics

Sales & Book Value

Annual Sales: $176.6M
Cash Flow: $14.2M
Price / Cash Flow: 62.58
Annual Sales: $7.37
Price / Book: 8.75

Profitability

EPS (TTM): 1.29400
Net Income (TTM): $77.7M
Gross Margin: $164.1M
Return on Equity: 21.63%
Return on Assets: 19.01%

Camurus AB Earnings Forecast

Key Camurus AB Financial Ratios

  • The Gross Profit Margin over the past 13 years for CAMRF is 92.92%.
  • The Selling, General & Administrative Expenses for CAMRF have been equal to 31.26% of Gross Profit Margin.
  • The Research & Development expenses have been 36.47% of Revenue.
  • The Interest Expense is 0.25% of Operating Income.
  • The Net Earning history of CAMRF is 22.94% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 6 years.

Camurus AB Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CAMRF
Website: camurus.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 10.61
Quick Ratio: 9.8

Price-to-Earnings

Trailing P/E Ratio: 94.31
Forward P/E Ratio: 0

CAMRF Technical Analysis vs Fundamental Analysis

Buy
54
Camurus AB (CAMRF) is a Buy

Is Camurus AB a Buy or a Sell?

  • Camurus AB stock is rated a Buy
    The current Camurus AB [CAMRF] share price is $64.23. The Score for CAMRF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.